{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T23:27:01Z","timestamp":1791415621111,"version":"4.3.3"},"reference-count":58,"publisher":"Oxford University Press (OUP)","issue":"12","funder":[{"DOI":"10.13039\/501100000024","name":"Canadian Institutes of Health Research","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000024","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000026","name":"NIDA","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000026","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"NIH","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["IJNPPY"],"published-print":{"date-parts":[[2016,12]]},"DOI":"10.1093\/ijnp\/pyw068","type":"journal-article","created":{"date-parts":[[2016,8,5]],"date-time":"2016-08-05T00:53:11Z","timestamp":1470358391000},"page":"pyw068","source":"Crossref","is-referenced-by-count":74,"title":["The CB<sub>1<\/sub>Neutral Antagonist AM4113 Retains the Therapeutic Efficacy of the Inverse Agonist Rimonabant for Nicotine Dependence and Weight Loss with Better Psychiatric Tolerability"],"prefix":"10.1093","volume":"19","author":[{"given":"Aliou B.","family":"Gueye","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yaroslaw","family":"Pryslawsky","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jose M.","family":"Trigo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nafsika","family":"Poulia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Foteini","family":"Delis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katerina","family":"Antoniou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Loureiro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Steve R.","family":"Laviolette","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kiran","family":"Vemuri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexandros","family":"Makriyannis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bernard","family":"Le Foll","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2016,8,4]]},"reference":[{"key":"2016123017454449000_19.12.pyw068.1","doi-asserted-by":"publisher","DOI":"10.1016\/j.nbd.2010.03.020"},{"key":"2016123017454449000_19.12.pyw068.2","doi-asserted-by":"crossref","unstructured":"Cahill K Ussher MH (2011) Cannabinoid type 1 receptor antagonists for smoking cessation. Cochrane Database Syst Rev CD005353.","DOI":"10.1002\/14651858.CD005353.pub4"},{"key":"2016123017454449000_19.12.pyw068.3","doi-asserted-by":"publisher","DOI":"10.1152\/ajpregu.00663.2007"},{"key":"2016123017454449000_19.12.pyw068.4","doi-asserted-by":"crossref","unstructured":"Chauvet C Nicolas C Thiriet N Lardeux MV Duranti A Solinas M (2014) Chronic stimulation of the tone of endogenous anandamide reduces cue- and stress-induced relapse in rats. Int J Neuropsychopharmacol 18.","DOI":"10.1093\/ijnp\/pyu025"},{"key":"2016123017454449000_19.12.pyw068.5","doi-asserted-by":"publisher","DOI":"10.1007\/BF02805981"},{"key":"2016123017454449000_19.12.pyw068.6","doi-asserted-by":"publisher","DOI":"10.1016\/j.pbb.2010.10.013"},{"key":"2016123017454449000_19.12.pyw068.7","doi-asserted-by":"publisher","DOI":"10.1016\/j.pbb.2005.01.024"},{"key":"2016123017454449000_19.12.pyw068.8","doi-asserted-by":"publisher","DOI":"10.1038\/sj.npp.1300541"},{"key":"2016123017454449000_19.12.pyw068.9","doi-asserted-by":"publisher","DOI":"10.1097\/00008877-200209000-00018"},{"key":"2016123017454449000_19.12.pyw068.10","doi-asserted-by":"publisher","DOI":"10.1007\/s11912-006-0077-6"},{"key":"2016123017454449000_19.12.pyw068.11","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbr.2010.11.013"},{"key":"2016123017454449000_19.12.pyw068.12","doi-asserted-by":"publisher","DOI":"10.1016\/j.tips.2005.06.002"},{"key":"2016123017454449000_19.12.pyw068.13","doi-asserted-by":"publisher","DOI":"10.1038\/nm1001-1151"},{"key":"2016123017454449000_19.12.pyw068.14","doi-asserted-by":"publisher","DOI":"10.1007\/BF00506193"},{"key":"2016123017454449000_19.12.pyw068.15","doi-asserted-by":"publisher","DOI":"10.1007\/s00213-005-0199-9"},{"key":"2016123017454449000_19.12.pyw068.16","doi-asserted-by":"publisher","DOI":"10.1007\/s002130000642"},{"key":"2016123017454449000_19.12.pyw068.17","doi-asserted-by":"publisher","DOI":"10.1007\/s00213-009-1569-5"},{"key":"2016123017454449000_19.12.pyw068.18","doi-asserted-by":"publisher","DOI":"10.1007\/s00213-005-0015-6"},{"key":"2016123017454449000_19.12.pyw068.19","doi-asserted-by":"publisher","DOI":"10.1016\/j.biopsych.2010.01.029"},{"key":"2016123017454449000_19.12.pyw068.20","doi-asserted-by":"publisher","DOI":"10.1111\/j.1369-1600.2011.00314.x"},{"key":"2016123017454449000_19.12.pyw068.21","doi-asserted-by":"publisher","DOI":"10.1001\/jama.296.1.47"},{"key":"2016123017454449000_19.12.pyw068.22","doi-asserted-by":"publisher","DOI":"10.1016\/j.pnpbp.2014.01.010"},{"key":"2016123017454449000_19.12.pyw068.23","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbr.2008.06.010"},{"key":"2016123017454449000_19.12.pyw068.24","doi-asserted-by":"publisher","DOI":"10.1517\/14728210902736568"},{"key":"2016123017454449000_19.12.pyw068.25","doi-asserted-by":"publisher","DOI":"10.1001\/jama.296.1.56"},{"key":"2016123017454449000_19.12.pyw068.26","doi-asserted-by":"crossref","unstructured":"Jutkiewicz EMA Vemuri VK Bergman J (2010) Pro-depressant-like effects of CB1 receptor inverse agonists\/antagonists in male Sprague-Dawley rats. FASEB J 24:581.7.","DOI":"10.1096\/fasebj.24.1_supplement.581.7"},{"key":"2016123017454449000_19.12.pyw068.27","doi-asserted-by":"publisher","DOI":"10.1124\/jpet.112.201962"},{"key":"2016123017454449000_19.12.pyw068.28","doi-asserted-by":"publisher","DOI":"10.1017\/S1461145709991064"},{"key":"2016123017454449000_19.12.pyw068.29","doi-asserted-by":"publisher","DOI":"10.1007\/s00213-007-0813-0"},{"key":"2016123017454449000_19.12.pyw068.30","doi-asserted-by":"publisher","DOI":"10.1007\/s00213-009-1481-z"},{"key":"2016123017454449000_19.12.pyw068.31","doi-asserted-by":"publisher","DOI":"10.1097\/00001756-200409150-00028"},{"key":"2016123017454449000_19.12.pyw068.32","doi-asserted-by":"publisher","DOI":"10.1124\/jpet.104.077974"},{"key":"2016123017454449000_19.12.pyw068.33","doi-asserted-by":"publisher","DOI":"10.1016\/j.pnpbp.2013.10.009"},{"key":"2016123017454449000_19.12.pyw068.34","doi-asserted-by":"publisher","DOI":"10.1038\/nrd2361"},{"key":"2016123017454449000_19.12.pyw068.35","doi-asserted-by":"publisher","DOI":"10.1038\/sj.npp.1301129"},{"key":"2016123017454449000_19.12.pyw068.36","doi-asserted-by":"publisher","DOI":"10.1016\/j.neuropharm.2005.03.016"},{"key":"2016123017454449000_19.12.pyw068.37","doi-asserted-by":"publisher","DOI":"10.1016\/j.tins.2006.01.008"},{"key":"2016123017454449000_19.12.pyw068.38","doi-asserted-by":"publisher","DOI":"10.1007\/s00213-007-0905-x"},{"key":"2016123017454449000_19.12.pyw068.39","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbr.2012.06.033"},{"key":"2016123017454449000_19.12.pyw068.40","doi-asserted-by":"publisher","DOI":"10.1016\/j.phrs.2013.06.001"},{"key":"2016123017454449000_19.12.pyw068.41","doi-asserted-by":"publisher","DOI":"10.1124\/jpet.108.138321"},{"key":"2016123017454449000_19.12.pyw068.42","doi-asserted-by":"publisher","DOI":"10.1038\/mp.2012.145"},{"key":"2016123017454449000_19.12.pyw068.43","doi-asserted-by":"publisher","DOI":"10.1016\/j.pbb.2012.10.008"},{"key":"2016123017454449000_19.12.pyw068.44","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(07)60033-6"},{"key":"2016123017454449000_19.12.pyw068.45","doi-asserted-by":"publisher","DOI":"10.1001\/jama.295.7.761"},{"key":"2016123017454449000_19.12.pyw068.46","doi-asserted-by":"publisher","DOI":"10.1007\/BF02245526"},{"key":"2016123017454449000_19.12.pyw068.47","unstructured":"Sanofi Aventis (2008) Sanofi-Aventis to discountinue all clinical trials with Rimonabant. http:\/\/en.sanofi.com\/Images\/14245_20081105_rimonabant_en.pdf. Paris, Retrieved November 5, 2008."},{"key":"2016123017454449000_19.12.pyw068.48","doi-asserted-by":"crossref","first-page":"494","DOI":"10.1016\/S0022-3565(25)32325-6","article-title":"Antidopaminergic properties of yohimbine","volume":"215","author":"Scatton","year":"1980","journal-title":"J Pharmacol Exp Ther"},{"key":"2016123017454449000_19.12.pyw068.49","doi-asserted-by":"publisher","DOI":"10.1007\/s00213-006-0498-9"},{"key":"2016123017454449000_19.12.pyw068.50","doi-asserted-by":"publisher","DOI":"10.1016\/j.neuropharm.2007.10.011"},{"key":"2016123017454449000_19.12.pyw068.51","doi-asserted-by":"publisher","DOI":"10.1038\/sj.npp.1301476"},{"key":"2016123017454449000_19.12.pyw068.52","doi-asserted-by":"publisher","DOI":"10.1007\/s00213-009-1602-8"},{"key":"2016123017454449000_19.12.pyw068.53","doi-asserted-by":"publisher","DOI":"10.1016\/j.euroneuro.2009.11.002"},{"key":"2016123017454449000_19.12.pyw068.54","doi-asserted-by":"publisher","DOI":"10.1016\/j.pbb.2008.07.013"},{"key":"2016123017454449000_19.12.pyw068.55","doi-asserted-by":"publisher","DOI":"10.1016\/j.neuropharm.2008.12.008"},{"key":"2016123017454449000_19.12.pyw068.56","doi-asserted-by":"publisher","DOI":"10.1093\/eurheartj\/ehn076"},{"key":"2016123017454449000_19.12.pyw068.57","doi-asserted-by":"crossref","first-page":"682","DOI":"10.1016\/S0022-3565(25)10401-1","article-title":"Yohimbine as a serotonergic agent: evidence from receptor binding and drug discrimination","volume":"263","author":"Winter","year":"1992","journal-title":"J Pharmacol Exp Ther"},{"key":"2016123017454449000_19.12.pyw068.58","unstructured":"World Health Organization (WHO, July, 2013) http:\/\/www.who.int\/mediacentre\/factsheets\/fs339\/en\/(www.who.int)(www.who.int(www.who.int)). Tobacco Fact sheet, Retrieved March 12, 2014."}],"container-title":["International Journal of Neuropsychopharmacology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/ijnp\/article-pdf\/19\/12\/pyw068\/14095213\/pyw068.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,6,4]],"date-time":"2025-06-04T13:02:21Z","timestamp":1749042141000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/ijnp\/article-lookup\/doi\/10.1093\/ijnp\/pyw068"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,8,4]]},"references-count":58,"journal-issue":{"issue":"12","published-online":{"date-parts":[[2016,12,30]]},"published-print":{"date-parts":[[2016,12]]}},"alternative-id":["10.1093\/ijnp\/pyw068"],"URL":"https:\/\/doi.org\/10.1093\/ijnp\/pyw068","relation":{},"ISSN":["1461-1457","1469-5111"],"issn-type":[{"value":"1461-1457","type":"print"},{"value":"1469-5111","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,8,4]]}}}